PKNOX2-DT: A Potential Drug Target and Biomarker (G103695364)

Target Name: PKNOX2-DT

NCBI ID: G103695364

PKNOX2-DT

Other Name(s): PKNOX2 divergent transcript | PKNOX2-AS1

PKNOX2-DT: A Potential Drug Target and Biomarker

The protein encoded by the gene PKNOX2-DT (PKNOX2 divergent transcript) is a potential drug target (or biomarker) for the treatment of various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. PKNOX2-DT is a key regulator of the neural development and progression, and its dysfunction has been implicated in the development and progression of many diseases. The discovery and characterization of PKNOX2-DT as a potential drug target and biomarker has the potential to lead to new therapeutic approaches for the treatment of these diseases.

Expression and Localization

PKNOX2-DT is a 21-kDa protein that is expressed in a variety of tissues and cells, including brain, heart, and peripheral tissues. It is predominantly expressed in the brain, with a Folding wave of 12.9 seconds and a total dynamic range (TDR) of 17.8 kDa. PKNOX2-DT is localized to the cytoplasm and the endoplasmic reticulum (ER), and its localization to the ER is dependent on its transmembrane domain (TMD).

Function and Interaction

PKNOX2-DT is a member of the PKNOX2 family of proteins, which are involved in the regulation of neural development and progression. The PKNOX2 family consists of four isoforms, including PKNOX2-DT, PKNOX2-MD (middle), PKNOX2-ME (edge ), and PKNOX2-LM (lateral). These isoforms are generated by alternative splicing of the PKNOX2 gene. PKNOX2-DT functions as a negative regulator of the neural-specific transcription factor, Nrx1. Nrx1 is a critical factor for the development and progression of neural tissues, and its expression is regulated by PKNOX2-DT.

PKNOX2-DT has been shown to interact with various cellular components, including Nrx1, TrkA, andStat3. Nrx1 is a nuclear transcription factor that plays a role in the regulation of neuronal differentiation and plasticity. TrkA is a non-coding RNA molecule that has been shown to interact with Nrx1 and may act as a negative regulator of Nrx1 activity. Stat3 is a nuclear transcription factor that is involved in the regulation of inflammation and immune responses.

Drug Targeting

The PKNOX2-DT protein is a potential drug target due to its involvement in the regulation of neural development and progression. The inhibition of PKNOX2-DT has been shown to promote the growth and survival of neural cells, and to inhibit the migration and invasion of cancer cells. These effects are thought to be due to the regulation of Nrx1 by PKNOX2-DT.

In addition to its potential therapeutic applications, the PKNOX2-DT protein also has the potential to serve as a biomarker for the diagnosis and prognosis of various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. The regulation of PKNOX2-DT by Nrx1 has has been implicated in the development and progression of many diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Therefore, the inhibition of PKNOX2-DT may be a useful biomarker for the diagnosis and prognosis of these diseases.

Conclusion

PKNOX2-DT is a protein that has the potential to be a drug target for the treatment of various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Its localization to the cytoplasm and ER, as well as its interaction with Nrx1 and TrkA, suggests that it plays an important role in the regulation of neural development and progression. The inhibition of PKNOX2-DT has been shown to promote the growth and survival of neural cells, and to inhibit the migration and invasion of cancer cells. These effects are thought to be due to the regulation of Nrx1 by PKNOX2-DT.

The PKNOX2-DT protein also has the potential to serve as a biomarker for the diagnosis and prognosis of various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. The regulation of PKNOX2-DT by Nrx1 has been implicated in the development and progression of many diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Therefore, the inhibition of PKNOX2-DT may be

Protein Name: PKNOX2 Divergent Transcript

The "PKNOX2-DT Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PKNOX2-DT comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets